SCHEMBL16551861

SCHEMBL16551861

COC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCN

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ LMNA P02545 1/20 0.51
▸ SLC15A2 Q16348 1/20 0.51
▸ CCR2 P41597 2/20 0.51
▸ SLC6A5 Q9Y345 1/20 0.50
▸ HTR1D P28221 2/20 0.49
▸ HTR2C P28335 2/20 0.49
▸ HTR1E P28566 2/20 0.49
▸ HTR2B P41595 2/20 0.49
▸ HTR2A P28223 1/20 0.49
▸ HTR3A P46098 1/20 0.49
▸ ITGB2 P05107 2/20 0.47
▸ ICAM1 P05362 2/20 0.47
▸ ITGAL P20701 2/20 0.47
▸ PDE5A O76074 1/20 0.45
▸ CPB2 Q96IY4 1/20 0.45
▸ ALOX5 P09917 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18381307 1.00 CYP3A4 (0.52) CYP3A4CYP2D6TSHRCYP2C19LMNA
SCHEMBL19051460 0.93 SLC15A2 (0.54) CYP3A4CYP2D6TSHRCYP2C19LMNA
SCHEMBL18381283 0.90 SLC6A5 (0.51) CYP3A4CYP2D6TSHRCYP2C19LMNA
SCHEMBL28270379 0.89 CYP3A4 (0.51) CYP3A4CYP2D6TSHRCYP2C19LMNA
SCHEMBL19051483 0.88 SLC6A5 (0.53) CYP3A4CYP2C19SLC15A2CCR2SLC6A5
SCHEMBL16364168 0.87 CYP3A4 (0.54) CYP3A4CYP2D6TSHRCYP2C19LMNA
SCHEMBL19059622 0.86 SLC6A5 (0.49) CYP3A4SLC15A2CCR2SLC6A5HTR1D
Carnosine SCHEMBL1160796 0.86 SLC15A2 (0.63) CYP3A4CYP2D6TSHRCYP2C19LMNA
Carnosine SCHEMBL22392772 0.86 SLC15A2 (0.63) CYP3A4CYP2D6TSHRCYP2C19LMNA
Carnosine SCHEMBL1161102 0.86 SLC15A2 (0.63) CYP3A4CYP2D6TSHRCYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046672-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DIABETES MOHAN M ALAPATI (IN) 2016-03-31 — — WO disclosed
WO-2016046669-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION AND NEUROLOGICAL DISEASES MOHAN M ALAPATI (IN) 2016-03-31 — — WO disclosed
WO-2015028927-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISEASES KANDULA MAHESH (IN) 2015-03-05 — — WO disclosed
Send feedback